Related Experiment Video
Updated: Aug 13, 2025
07:43
Cavernous Nerve Stimulation and Recording of Intracavernous Pressure in a Rat
Published on: April 23, 2018
12.7K
Established Immortalized Cavernous Endothelial Cells Improve Erectile Dysfunction in Rats with Cavernous Nerve Injury
Sang Hong Bak1, Jae Heon Kim2, Seung U Kim3
1Research Institute, Humetacell Inc., Bucheon 14786, Gyeonggi, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|January 21, 2023
Summary
Researchers immortalized rat penile endothelial cells (rEC) into vREC, which successfully repaired erectile dysfunction in rats with cavernous nerve injury. This new cell line aids erectile dysfunction research and drug screening.
Area of Science:
- Regenerative Medicine
- Urology
- Cell Biology
Background:
- Erectile dysfunction (ED) is often caused by damage to penile endothelial cells (ECs).
- Current methods using primary ECs face limitations due to restricted growth potential.
- Developing immortalized ECs is crucial for studying and treating ED.
Purpose of the Study:
- To establish immortalized rat penile cavernous ECs (vREC).
- To evaluate the therapeutic potential of vREC in repairing erectile dysfunction following cavernous nerve injury (CNI) in rats.
Main Methods:
- Rat penile ECs were isolated and immortalized using a retroviral vector encoding the v-myc oncogene.
- Immunohistochemistry, RT-PCR, and flow cytometry confirmed vREC identity and EC markers (CD31, vWF).
- vREC were transplanted into rats with CNI, and erectile function was assessed at 2 and 4 weeks.
Main Results:
- vREC exhibited characteristic EC markers and were successfully established.
- Rats with CNI showed significantly impaired erectile function compared to controls.
- vREC transplantation significantly improved erectile function in rats with CNI.
Conclusions:
- Immortalized rat penile ECs (vREC) were successfully established.
- vREC demonstrated efficacy in repairing erectile dysfunction caused by CNI in a rat model.
- This vREC cell line offers a valuable tool for ED research and therapeutic development.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
219
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
219